Isoflavone ME-344 Disrupts Redox Homeostasis and Mitochondrial Function by Targeting Heme Oxygenase 1.

Abstract

ME-344 is a second-generation isoflavone with unusual cytotoxic properties that is in clinical testing in cancer. To identify targets that contribute to its anticancer activity and therapeutic index, we used lung cancer cell lines that are naturally sensitive or resistant to ME-344. Drug-induced apoptosis was linked with enhanced levels of reactive oxygen species and this initiated a nuclear erythroid factor 2-like 2 signaling response, downstream of which, heme oxygenase 1 (HO-1) was also found to be time-dependently inhibited by ME-344. ME-344 specifically bound to, and altered, HO-1 structure and increased HO-1 translocation from the rough endoplasmic reticulum to mitochondria, but only in drug-sensitive cells. These effects did not occur in either drug-resistant or primary lung fibroblasts with lower HO-1 basal levels. HO-1 was confirmed as a drug target by using surface plasmon resonance technology and through interaction with a clickable ME-344 compound (M2F) and subsequent proteomic analyses, showing direct binding of ME-344 with HO-1. Proteomic analysis showed that clusters of mitochondrial proteins, including voltage-dependent anion-selective channels, were also impacted by ME-344. Human lung cancer biopsies expressed higher levels of Nrf2 and HO-1 compared with normal tissues. Overall, our data show that ME-344 inhibits HO-1 and impacts its mitochondrial translocation. Other mitochondrial proteins are also affected, resulting in interference in tumor cell redox homeostasis and mitochondrial function. These factors contribute to a beneficial therapeutic index and support continued clinical development of ME-344. SIGNIFICANCE: A novel cytotoxic isoflavone is shown to inhibit heme oxygenase, a desirable yet elusive target that disrupts redox homeostasis causing cell death.

• Authors: Leilei Zhang, Jie Zhang, Zhiwei Ye, Yefim Manevich, Lauren E Ball, Jennifer R Bethard, Yu-Lin Jiang, Ann-Marie Broome, Annamarie C Dalton, Gavin Y Wang, Danyelle M Townsend, Kenneth D Tew
• Journal: Cancer research (Cancer Res) Vol. 79 Issue 16 Pg. 4072-4085 (08 15 2019) ISSN: 1538-7445 [Electronic] United States
• PMID: 31227482 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: ©2019 American Association for Cancer Research.

Chemical References

• Enzyme Inhibitors
• Isoflavones
• NF-E2-Related Factor 2
• NFE2L2 protein, human
• Reactive Oxygen Species
• ME-344
• HMOX1 protein, human
• Heme Oxygenase-1

Topics

• Apoptosis (drug effects)
• Cell Line, Tumor
• Drug Resistance, Neoplasm (drug effects)
• Energy Metabolism (drug effects)
• Enzyme Inhibitors (pharmacology)
• Heme Oxygenase-1 (antagonists & inhibitors, metabolism)
• Humans
• Isoflavones (metabolism, pharmacology)
• Lung Neoplasms (drug therapy, metabolism, pathology)
• Mitochondria (drug effects, metabolism)
• Molecular Targeted Therapy
• NF-E2-Related Factor 2 (metabolism)
• Oxidation-Reduction
• Reactive Oxygen Species (metabolism)
• Unfolded Protein Response (drug effects)